Inspire Medical Systems Inc (INSP)
Industry Medical Devices
This stock can be held in an Investment ISA and an Investment Account
Sell
$128.50
Buy
$213.60
$-6.69 (-4.87%)
Prices updated at 12 Dec 2025, 22:56 EST
| Prices minimum 15 mins delay
Prices in USD
Inspire Medical Systems Inc operates as a medical technology company. The firm develops implantable neurostimulation systems to treat obstructive sleep apnea.
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Income statement
Year | 2023 | 2024 |
|---|---|---|
| 625m | 803m | |
| 528m | 680m | |
| -40m | 36m | |
| -6.45 | 4.49 | |
| -21m | 54m | |
| -17m | 65m | |
| Sales, General and administrative | 452m | 530m |
| Interest expenses | - | 22,000 |
| Provision for income taxes | 1m | 5m |
| Operating expenses | 568m | 644m |
| Income before taxes | -20m | 58m |
| Net income available to common shareholders | -21m | 54m |
| -0.72 | 1.8 | |
| Net interest income | 21m | 23m |
| Advertising and promotion | - | - |
| Net investment income, net | - | - |
| Realised capital gains (losses), net | - | - |
| Total benefits, claims and expenses | - | - |
| Earnings per share (diluted) | -0.72 | 1.75 |
| Free cash flow per share | 0.2781 | 1.2606 |
| Book value/share | 18.409 | 23.4216 |
| Debt equity ratio | 0.043398 | 0.043554 |
Balance sheet
Year | 2023 | 2024 |
|---|---|---|
| Current assets | 594m | 631m |
| Current liabilities | 78m | 89m |
| Total capital | 573m | 690m |
| Total debt | 25m | 32m |
| Total equity | 573m | 690m |
| Total non current liabilities | - | - |
| Loans | - | - |
| Total assets | 677m | 808m |
| Total liabilities | - | - |
| Cash and cash equivalents | 186m | 150m |
| Common stock | 30m | 30m |
Cash flow
Year | 2023 | 2024 |
|---|---|---|
| Cash at beginning of period | 442m | 186m |
| Cash dividends paid | - | - |
| 1m | 91m | |
| Investments (gains) losses | -295m | -113m |
| 186m | 150m | |
| Net income | - | - |
| 25m | 130m | |
| -24m | -39m |
The figures shown in the tables are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.